Kozak & Associates’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Hold
930
0.06% 58
2026
Q1
$249K Buy
930
+1
+0.1% +$224 0.05% 64
2025
Q4
$203K Buy
929
+1
+0.1% +$156 0.04% 72
2025
Q3
$137K Buy
928
+2
+0.2% +$212 0.03% 96
2025
Q2
$92.5K Buy
926
+2
+0.2% +$159 0.02% 112
2025
Q1
$62.7K Buy
924
+6
+0.7% +$472 0.02% 118
2024
Q4
$69K Sell
918
-33,112
-97% -$2.51M 0.02% 120
2024
Q3
$252K Buy
34,030
+30,640
+904% +$2.66M 0.06% 72
2024
Q2
$368K Hold
3,390
0.09% 52
2024
Q1
$320K Buy
3,390
+1,600
+89% +$141K 0.09% 63
2023
Q4
$136K Buy
1,790
+520
+41% +$35.4K 0.04% 85
2023
Q3
$79.5K Buy
1,270
+110
+9% +$7.23K 0.03% 114
2023
Q2
$75.8K Hold
1,160
0.03% 116
2023
Q1
$61.7K Hold
1,160
0.03% 133
2022
Q4
$49K Sell
1,160
-1,170
-50% -$48.9K 0.02% 150
2022
Q3
$76K Hold
2,330
0.05% 119
2022
Q2
$99K Buy
2,330
+380
+19% +$18.1K 0.07% 106
2022
Q1
$97K Hold
1,950
0.06% 116
2021
Q4
$97K Buy
1,950
+870
+81% +$54.5K 0.06% 116
2021
Q3
$68K Buy
+1,080
New +$65.7K 0.04% 135

Other funds holding LRCX

Kozak & Associates's LRCX Position: Q2 2026 in Review

Kozak & Associates held its Lam Research (LRCX) position steady in Q2 2026 at 930 shares worth $364K. The position accounts for 0.06% of the portfolio, ranked #58.

Kozak & Associates first reported a position in LRCX in Q3 2021 and has held it in 20 quarters since. The position peaked at $368K in Q2 2024. 889 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Kozak & Associates held 930 shares of Lam Research worth $364K as of Q2 2026.
  • Kozak & Associates left its Lam Research share count unchanged in Q2 2026.
  • Lam Research made up 0.06% of Kozak & Associates's portfolio in Q2 2026, its #58 holding.
  • Kozak & Associates first reported a position in Lam Research in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's Lam Research position peaked at $368K in Q2 2024.
  • 889 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.